Breaking News, Financial News

Financial Report: Johnson & Johnson

Earnings drop 49% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Johnson & Johnson   2Q Revenues: $16.5 billion (-1%) 2Q Earnings: $1.4 billion (-49%) YTD Revenues: $32.6 billion (flat) YTD Earnings: $5.3 billion (-15%) Comments: Worldwide Pharmaceutical sales were $6.3 billion (+1%) in the quarter with a negative impact from currency of 4.2%. Domestic sales were down 5%. International sales increased 7%. Remicade sales were $1.5 billion, up 11% in the quarter. Levaquin sales were down 90% to $16 million due to generic competition. Worldwide Consumer...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters